PLoS ONE (Jan 2016)

Declining Trend of Hepatitis A Seroepidemiology in Association with Improved Public Health and Economic Status of Thailand.

  • Pattaratida Sa-nguanmoo,
  • Nawarat Posuwan,
  • Preeyaporn Vichaiwattana,
  • Viboonsak Vuthitanachot,
  • Siriporn Saelao,
  • Monthana Foonoi,
  • Apinya Fakthongyoo,
  • Jamorn Makaroon,
  • Klaita Srisingh,
  • Duangporn Asawarachun,
  • Somchai Owatanapanich,
  • Norra Wutthiratkowit,
  • Kraisorn Tohtubtiang,
  • Sompong Vongpunsawad,
  • Pornsak Yoocharoen,
  • Yong Poovorawan

DOI
https://doi.org/10.1371/journal.pone.0151304
Journal volume & issue
Vol. 11, no. 3
p. e0151304

Abstract

Read online

Hepatitis A virus (HAV) is transmitted via the fecal-oral route from contaminated food or water. As part of the most recent survey of viral hepatitis burden in Thailand, we analyzed the current seroprevalence of HAV in the country and compared with data dating back to 1971. From March to October, 2014, a total of 4,260 individuals between one month and 71 years of age from different geographical regions (North = 961; Central = 1,125; Northeast = 1,109; South = 1,065) were screened for anti-HAV IgG antibody using an automated chemiluminescent microparticle immunoassay. Overall, 34.53% (1,471/4,260) possessed anti-HAV IgG antibody, and the age-standardized seroprevalence was 48.6%. Seroprevalence rates were 27.3% (North), 30.8% (Central), 33.8% (Northeast) and 45.8% (South) and were markedly lower than in the past studies especially among younger age groups. The overall trend showed an increase in the age by which 50% of the population were anti-HAV IgG antibody: 4.48 years (1971-1972), 6 (1976), 12.49 (1990), 36.02 (2004) and 42.03 (2014).This suggests that Thailand is transitioning from low to very low HAV endemicity. Lower prevalence of HAV correlated with improved healthcare system as measured by decreased infant mortality rate and improved national economy based on increased GDP per capita. The aging HAV immuno-naïve population may be rendered susceptible to potential HAV outbreaks similar to those in industrialized countries and may benefit from targeted vaccination of high-risk groups.